BIO Statement on Nomination of Dr. Robert Califf as FDA Commissioner

WASHINGTON, D.C. (September 16, 2015) - Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement today commending President Barack Obama for his nomination of Dr. Robert Califf as Commissioner of the Food and Drug Administration (FDA):

“BIO is encouraged by the nomination of Dr. Califf as the next Commissioner of Food and Drugs and we urge the Senate to consider his confirmation as soon as possible.  Dr. Califf is a respected cardiologist and clinical trial expert with a firm understanding of the challenges and opportunities of 21st century medicine.  The FDA deserves a strong, confirmed Commissioner to effectively fulfill its expanding obligations and maintain appropriate standards for the safety and effectiveness of advanced therapies.”

“The Administration’s commitment to stable leadership at FDA will help the Agency keep pace with the rapidly evolving science of drug development, and recruit and retain world-class scientists and medical reviewers.”

“We look forward to working with the next Commissioner and the Congress to ensure that the FDA has the resources necessary to protect America’s patients and consumers.”

Upcoming BIO Events